Interestingly, a recent single-cell sequencing study of ESCC samples has identified immune characteristics associated with neoadjuvant immunochemotherapy, revealing that LRRC15+ fibroblasts and SPP1+ macrophages are critical targets of treatment resistance [159]. This evidence concerns the gene LRRC15 and esophageal squamous cell carcinoma.